Answer
Belzutifan can decrease hormonal contraceptive concentrations and reduce their efficacy, potentially causing contraceptive failure or increased breakthrough bleeding.
Sources for this answer
- WELIREG 40 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 9Document updated
Sources checked